Company / strategic investorRegistered location :New York

JPMorgan Chase & CoDeclared Swiss shareholdings

JPMorgan Chase & Co: 28 Swiss companies with a declared holding, including Rieter Holding AG, Santhera Pharmaceuticals Holding AG, DocMorris AG. Latest filing: 29.10.2026.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
…
Swiss companies held
28
Largest position
62,45 %
Rieter Holding AG
12-month trend
Stable
2 rate rises · 2 rate falls
Latest filing
29.10.2026
Active since 2008

Declared Swiss portfolio

Latest declared rate per company

Sector allocation

Share of companies held
Show 19 more companies
How to read these figures?

Rates come from the 471 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure25 controls

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

20

visible history: 467

90 days · Downward crossings

0

visible history: 0

First disclosure: 06.05.2008Last disclosure: 29.10.2026

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings
162
Rights / derivatives
515
Sale positions
189
Securities lending
134

Latest shareholding disclosures

Show 37 older disclosures
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

7.571%Voting rights acquired06.10.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

7.852%Voting rights acquired01.10.2026
PurchaseShareholdings

Kuros Biosciences AG

JPMorgan Chase & Co · Single shareholder

5.39%Voting rights acquired30.09.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

7.527%Voting rights acquired26.09.2026
Below thresholdShareholdings

Kuros Biosciences AG

JPMorgan Chase & Co · Single shareholder

3%Below threshold24.09.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

11.43%Voting rights acquired23.09.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

10.048%Voting rights acquired23.09.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

7.082%Voting rights acquired23.09.2026
PurchaseShareholdings

Kuros Biosciences AG

JPMorgan Chase & Co · Single shareholder

5.087%Voting rights acquired18.09.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

12.614%Voting rights acquired18.09.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

13.531%Voting rights acquired16.09.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

14.032%Voting rights acquired16.09.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

14.983%Voting rights acquired02.09.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

15.192%Voting rights acquired02.09.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

15.053%Voting rights acquired29.08.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

15.064%Voting rights acquired29.08.2026
PurchaseShareholdings

Kuros Biosciences AG

JPMorgan Chase & Co · Single shareholder

7.014%Voting rights acquired27.08.2026
PurchaseShareholdings

Kuros Biosciences AG

JPMorgan Chase & Co · Single shareholder

4.486%Voting rights acquired27.08.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

12.66%Voting rights acquired23.07.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

13.451%Voting rights acquired23.07.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

13.025%Voting rights acquired18.07.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

13.643%Voting rights acquired18.07.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

13.724%Voting rights acquired18.07.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

11.844%Voting rights acquired12.07.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

12.194%Voting rights acquired12.07.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

11.952%Voting rights acquired12.07.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

12.263%Voting rights acquired08.07.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

12.155%Voting rights acquired26.06.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

12.434%Voting rights acquired19.06.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

11.373%Voting rights acquired11.06.2026
Below thresholdShareholdings

Basilea Pharmaceutica AG, Allschwil

JPMorgan Chase & Co · Single shareholder

3%Below threshold19.05.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

10.547%Voting rights acquired16.05.2026
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

JPMorgan Chase & Co · Single shareholder

9.956%Voting rights acquired15.05.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

9.638%Voting rights acquired08.04.2026
PurchaseShareholdings

DocMorris AG

JPMorgan Chase & Co · Single shareholder

9.844%Voting rights acquired31.03.2026
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

JPMorgan Chase & Co · Single shareholder

14.846%Voting rights acquired28.03.2026
PurchaseShareholdings

Basilea Pharmaceutica AG, Allschwil

JPMorgan Chase & Co · Single shareholder

3.066%Voting rights acquired25.03.2026

insider24.ch

Follow JPMorgan Chase & Co’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Management purchases in this portfolio

Loading activity…

    These figures aggregate public disclosures. They are not investment advice.

    Common questions

    Which Swiss companies are in JPMorgan Chase & Co’s disclosed portfolio?

    Rieter Holding AG, Santhera Pharmaceuticals Holding AG, DocMorris AG, Schaffner Holding AG, Kuros Biosciences AG, Implenia AG, TEMENOS AG, Sunrise Communications Group AG, SFS Group AG, Galenica AG, Aluflexpack AG, Landis+Gyr Group AG, Forbo Holding AG, Siegfried Holding AG, Avolta AG, Newron Pharmaceuticals S.p.A., Kardex Holding AG, R&S Group Holding AG, Clariant AG, Swissquote Group Holding Ltd, ams-OSRAM AG, gategroup Holding AG, Autoneum Holding AG, Georg Fischer AG, Logitech International S.A., Acino Holding AG, lastminute.com N.V., mobilezone holding ag.

    What is JPMorgan Chase & Co’s latest disclosure?

    The latest available disclosure was published on 29.10.2026 and concerns DocMorris AG. Threshold disclosures do not describe every purchase or sale.

    Explore further

    Recent insider purchases

    What are insiders doing at companies disclosed by this shareholder?

    All purchases this week

    Insider barometer

    Compare insider purchases and sales across the Swiss stock exchange over 30 days.

    View the Swiss barometer

    These signals are not investment advice.